Eos Advisory is a St Andrews-based investment firm that invests in and commercialises science and technology ventures, from local seed-stage to global scale, with a focus on improving lives through healthcare, life sciences, and environmental sustainability. It operates through three pillars: the Eos Syndicate, Eos Innovation Fund, and Eos Venture Partnerships.
39% of their portfolio is in Healthcare. Deal activity decreased year-over-year (2 deals in the last 12 months vs 4 prior). Their most common stage is seed (43% of deals). Average disclosed round size is $5.2M (across 5 rounds with reported amounts).
Portfolio
18
Fund Size
—
Top Stage
Seed
Last 12 Mo
2
Team
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
23 investments
| Company | Round | Amount | Date |
|---|---|---|---|
 Bioliberty | Series A | $8.2M | Mar 2026 |
 Nami Surgical | Seed | — | Feb 2026 |
 Bioliberty | Series A | — | Jan 2026 |
| SScarlet Therapeutics | Seed | — | Jan 2026 |
| Bioliberty | Series A | $8.2M | Jan 2026 |
 Ensilitech | Seed | — | Aug 2025 |
| LLaverock Therapeutics | Seed | — | Jun 2025 |
 Laverock | Seed | — | Jun 2025 |
 Dxcover | Unknown | $6.2M | Jan 2025 |
| Bioliberty | Series A | $2M | Jan 2025 |
 Naturbeads | Series A | — | Nov 2024 |
| CChromacity | Unknown | $1.3M | Jul 2024 |
 Cumulus Oncology | Seed | — | Jan 2024 |
 Neupulse | Unknown | — | Jan 2024 |
 Concinnity Genetics | Seed | — | Jan 2024 |
 Penrhos Bio | Series A | — | Oct 2023 |
| Dxcover | Series A | — | Jan 2023 |
| Bioliberty | Seed | — | Jan 2023 |
 Carcinotech | Pre-Seed | — | Jan 2021 |
| Penrhos Bio | Seed | — | Jan 2021 |
 RAB Microfluidics | Unknown | — | — |
 TaiSan | Pre-Seed | — | — |
 Scarlet | Seed | — | — |
Top Co-Investors
Old College Capital5 shared
Mercia Asset Management4 shared
Calculus Capital3 shared
Innovate UK2 shared
Eli Lilly and Company2 shared
SCVC2 shared
Penny Jar Capital1 shared
Gaingels1 shared
Empirical Ventures1 shared
#ANGELS1 shared
CDP Venture Capital1 shared
private angel investors1 shared
Archangel1 shared
Future Planet Capital1 shared
Macmillan Cancer Support1 shared
Maven1 shared
Last updated: 7 October 2026